美国食品控股 USFD 深 沪
等待开盘 02-05 09:30:00 美东时间
87.82
-0.070
-0.08%
华盛通- 最 高87.92
- 今 开86.45
- 成交量 677.64万股
- 最 低 84.23
- 昨 收 87.89
- 总市值 197.60亿
- 52周最高 88.315
- 市盈率 静 43.38
- 换手率 3.01%
- 52周最低 57.3605
- 委 比 -0.56%
- 总股本 2.25亿
- 历史最高 88.315
- 量 比 2.37
- 振 幅 4.20%
- 历史最低 8.32
- 每 手 1
- 风险率 5.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
Citigroup Maintains Buy on US Foods Holdings, Raises Price Target to $95
Citigroup analyst Karen Holthouse maintains US Foods Holdings (NYSE:USFD) with a Buy and raises the price target from $90 to $95.
01-27 23:25
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Guggenheim Maintains Buy on US Foods Holdings, Raises Price Target to $95
Guggenheim analyst John Heinbockel maintains US Foods Holdings (NYSE:USFD) with a Buy and raises the price target from $88 to $95.
01-20 22:23
US Foods reaffirms 2025 guidance ahead of ICR presentation
US Foods Holding Corp. (USFD) provided an update on Monday ahead of the company's appearance at the ICR Conference. The foodservice industry supplier said that it is reaffirming its prior fiscal year ...
01-12 19:54
US Foods Holding Reaffirms FY25 Guidance Of Net Sales Growth Of 4%-5%; Adj. EBITDA Growth Of 10%-12%, And Adj. EPS Growth Of 24%-26%
US Foods Holding Corp. (NYSE:USFD) announced today that it is reaffirming its fiscal year 2025 guidance previously announced on its third quarter earnings call on Nov. 6, 2025.Outlook for Fiscal Year 20251The Company is
01-12 19:50
US Foods and Performance Food end their pursuit of a merger
US Foods Holding Corp. (USFD) and Performance Food Group Company (PFGC) announced on Monday that they have ended their pursuit of a merger. US Foods (USFD) CEO Dave Flitman said the board and executi...
2025-11-24 19:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
